摘要 |
Compounds having the formula (I), or a stereoisomer or pharmaceutically-acceptable salt, or hydrate thereof, are useful as factor VIIa inhibitors, wherein X is -NR<SUB>6</SUB>S(O)<SUB>p</SUB>R<SUB>16</SUB>; W is hydrogen or -(CR<SUB>7</SUB>R<SUB>8</SUB>)<SUB>q-</SUB>W<SUB>1</SUB>; W<SUB>1 </SUB>is hydrogen or a bond with R<SUB>6</SUB>; Z is a 5 -membered heteroaryl group, a five to six membered heterocyclo or cycloalkyl group, a 9 to 10 membered bicyclic aryl or heteroaryl, or a six membered aryl or heteroaryl, and R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>6</SUB>, R<SUB>7</SUB>, and R<SUB>16 </SUB>are as defined in the specification.
|